Swiss National Bank Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Swiss National Bank

$143 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$144.95 - $152.29 $275,405 - $289,351	1,900 Added 1.34%	143,200 $21.6 Million
Q2 2022 Aug 09, 2022	BUY	$83.14 - $145.99 $157,966 - $277,381	1,900 Added 1.36%	141,300 $20.6 Million
Q1 2022 May 09, 2022	BUY	$110.08 - $142.92 $1.08 Million - $1.4 Million	9,800 Added 7.56%	139,400 $16.5 Million
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $19,946 - $29,695	200 Added 0.15%	129,600 $17.9 Million
Q3 2021 Nov 08, 2021	BUY	$98.85 - $138.91 $1.04 Million - $1.46 Million	10,500 Added 8.83%	129,400 $18 Million
Q2 2021 Aug 06, 2021	BUY	$65.78 - $105.02 $157,872 - $252,048	2,400 Added 2.06%	118,900 $11.5 Million
Q1 2021 May 07, 2021	BUY	$64.07 - $91.75 $115,325 - $165,150	1,800 Added 1.57%	116,500 $7.96 Million
Q4 2020 Feb 05, 2021	BUY	$65.07 - $98.24 $123,632 - $186,656	1,900 Added 1.68%	114,700 $9.83 Million
Q3 2020 Nov 09, 2020	BUY	$59.04 - $77.95 $129,888 - $171,490	2,200 Added 1.99%	112,800 $7.33 Million
Q2 2020 Aug 05, 2020	BUY	$29.01 - $74.23 $713,646 - $1.83 Million	24,600 Added 28.6%	110,600 $8.09 Million
Q1 2020 May 08, 2020	BUY	$27.51 - $57.29 $33,012 - $68,748	1,200 Added 1.42%	86,000 $2.93 Million
Q4 2019 Feb 06, 2020	BUY	$40.86 - $57.65 $106,236 - $149,890	2,600 Added 3.16%	84,800 $4.62 Million
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $26,166 - $34,629	700 Added 0.86%	82,200 $3.43 Million
Q2 2019 Aug 02, 2019	BUY	$39.79 - $67.01 $1.78 Million - $3 Million	44,700 Added 121.47%	81,500 $3.57 Million
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $44,876 - $69,277	1,300 Added 3.66%	36,800 $1.89 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $47,600 - $68,640	1,600 Added 4.72%	35,500 $1.31 Million
Q3 2018 Nov 08, 2018	BUY	$32.79 - $43.0 $85,254 - $111,800	2,600 Added 8.31%	33,900 $1.27 Million
Q1 2018 May 04, 2018	BUY	$22.49 - $34.56 $359,840 - $552,960	16,000 Added 104.58%	31,300 $806,000
Q4 2017 Feb 07, 2018	BUY	$20.44 - $35.56 $312,732 - $544,068	15,300	15,300 $413,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account